Evidence map›Paper›PMID 34858513›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2021

Efficacy and Safety of Ashwagandha Root Extract on Cognitive Functions in Healthy, Stressed Adults: A Randomized, Double-Blind, Placebo-Controlled Study.

Kumarpillai Gopukumar, Shefali Thanawala, Venkateswarlu Somepalli, T S Sathyanaryana Rao, Vijaya Bhaskar Thamatam, Sanjaya Chauhan

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07647081 (Female Adversity and Biology), which is not on this map. Cited by 43 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 5 pooled it
13.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07647081 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Female Adversity and Biology: Stress Reduction

TypeinterventionalSponsorOklahoma State University Center for Health SciencesRan2026 to 2027Enrolled30ConditionsStressArmsPlacebo, KSM-66 Ashwagandha
3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 5 syntheses or guidelines pooled it, 82 citations in OpenAlex.

  1. Effects ofFrontiers in pharmacology · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Effects ofNutrients · 2023
    Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Effects ofNutrients · 2024
    Trial
  13. Exploring the efficacy and safety of a novel standardized ashwagandha (Journal of psychopharmacology (Oxford, England) · 2023
    Trial
  14. Observational
  15. Nutraceutical Applications ofFoods (Basel, Switzerland) · 2026
    Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Kumarpillai GopukumarBengaluru Neuro Centre, Bengaluru, Karnataka 560003, India.
Shefali ThanawalaInventia Healthcare Ltd., Mumbai, Maharashtra 400069, India.ORCID https://orcid.org/0000-0001-6887-0772
Venkateswarlu SomepalliLaila Nutraceuticals, Vijayawada, Andhra Pradesh 520007, India.ORCID https://orcid.org/0000-0002-4625-6277
T S Sathyanaryana RaoSumana Vinayaka Nursing Home, Mandya, Karnataka 571401, India.
Vijaya Bhaskar ThamatamIn Vitro Research Solutions (iVRS) Pvt Ltd., Bengaluru, Karnataka 560092, India.ORCID https://orcid.org/0000-0001-5261-6729
Sanjaya ChauhanIn Vitro Research Solutions (iVRS) Pvt Ltd., Bengaluru, Karnataka 560092, India.
Bangalore Diabetes Centre · INInventia (India) · INLaila Impex (India) · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe global prevalence of stress is increasing. Stress adversely affects cognitive ability, sleep quality, and overall psychological well-being. Ashwagandha (

methodsSubjects (130 healthy cognitively sound adults [20-55 years, body mass index:18-29 kg/m

resultsOnly 125 completed the study and were evaluated. The Cambridge Neuropsychological Test Automated Battery (CANTAB) reported significantly improved recall memory, and the total error rate in recalling patterns significantly decreased at visit 4 in the Ashwagandha SR group vs. the placebo group (first attempt memory score:12.9 ± 6.7 vs. 10.1 ± 6.3; total errors:17.5 ± 23.3 vs. 27.7 ± 23.6). At visit 4, lower PSS-10 score (13.0 ± 5.0 vs. 18.7 ± 4.6;

conclusionsThis is the first clinical study assessing Ashwagandha SR for its safety and efficacy. Treatment with one Ashwagandha SR capsule once daily for 90 days improved memory and focus, psychological well-being, and sleep quality, reduced stress levels, and was safe and well-tolerated.

Identifiers

PMID34858513
PMCPMC8632422
OpenAlexW3215988379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.